Abiopharma

The U.S. Food and Drug Administration has informed Sanofi that its planned Actual Use Trial (AUT) to support the Rx-to-OTC switch for Cialis (tadalafil) has been placed on clinical hold due to matters surrounding the protocol design. Sanofi continues to work with FDA to move the Cials program forward and will engage the Agency in upcoming meetings.